ORIGINAL RESEARCH
Accepted on 19 May 2025
Sirtuin 5 inhibits mitochondrial metabolism in liver cancer cells and promotes apoptosis by mediating the desuccinylation of CS
doi 10.3389/fimmu.2025.1560989
- Frontiers in Medicine
- Translational Medicine
- Research Topics
- Hepatocellular Carcinoma: Novel Treatment Strategies - Volume III
Hepatocellular Carcinoma: Novel Treatment Strategies - Volume III
11k
Total downloads
37k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 28 Mar 2025
A prediction model based on machine learning: prognosis of HBV-induced HCC male patients with smoking and drinking habits after local ablation treatment
doi 10.3389/fimmu.2025.1464863
- 1,279 views
REVIEW
Published on 03 Mar 2025
Adverse events associated with hepatic arterial infusion chemotherapy and its combination therapies in hepatocellular carcinoma: a systematic review
doi 10.3389/fimmu.2025.1531249
- 1,160 views
ORIGINAL RESEARCH
Published on 13 Feb 2025
Creation of an innovative diagnostic framework for hepatocellular carcinoma employing bioinformatics techniques focused on senescence-related and pyroptosis-related genes
doi 10.3389/fonc.2025.1485421
- 1,059 views
ORIGINAL RESEARCH
Published on 10 Jan 2025
Hepatic arterial infusion chemotherapy combined with immune checkpoint inhibitors and molecular targeted therapies for advanced infiltrative hepatocellular carcinoma: a single-center experience
doi 10.3389/fimmu.2024.1474442
- 916 views
ORIGINAL RESEARCH
Published on 12 Dec 2024
Prognostic significance of early alpha fetoprotein and des-gamma carboxy prothrombin responses in unresectable hepatocellular carcinoma patients undergoing triple combination therapy
doi 10.3389/fimmu.2024.1508028
- 814 views
- 1 citation
ORIGINAL RESEARCH
Published on 12 Dec 2024
Improved survival with second-line hepatic arterial infusion chemotherapy after atezolizumab-bevacizumab failure in hepatocellular carcinoma
doi 10.3389/fonc.2024.1495321
- 941 views
- 1 citation
ORIGINAL RESEARCH
Published on 05 Dec 2024
Immune-checkpoint HLA-G gene polymorphisms, 3’-UTR types and their association with hepatocellular carcinoma and treatment response in Indian population
doi 10.3389/fimmu.2024.1459749
- 975 views
BRIEF RESEARCH REPORT
Published on 22 Nov 2024
Superior survival benefits of triple combination immunotherapy compared to standard chemotherapy as second-line treatment for advanced biliary tract cancer: a retrospective analysis
doi 10.3389/fonc.2024.1482909
- 768 views
CASE REPORT
Published on 20 Nov 2024
The survival and safety of metastatic hepatocellular carcinoma treated with lenalidomide as second-line therapy: a case report and review of the literature
doi 10.3389/fonc.2024.1461936
- 621 views
SYSTEMATIC REVIEW
Published on 11 Nov 2024
Comparison of adjuvant treatment regimens for high-risk hepatocellular carcinoma: a Bayesian network meta analysis and systematic review
doi 10.3389/fimmu.2024.1487353
- 1,676 views
MINI REVIEW
Published on 25 Oct 2024
Therapeutic advances in hepatocellular carcinoma: an update from the 2024 ASCO annual meeting
doi 10.3389/fonc.2024.1453412
- 3,668 views
- 2 citations
Published in
Frontiers in Medicine
Translational Medicine
Participating Journals
Frontiers in Immunology
- 5.7 impact factor
- 9.8 citescore
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore